ID: ALA3133144

Max Phase: Preclinical

Molecular Formula: C15H9F3N2O2

Molecular Weight: 306.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1nc(-c2ccc(C(F)(F)F)cc2)n2ccccc12

Standard InChI:  InChI=1S/C15H9F3N2O2/c16-15(17,18)10-6-4-9(5-7-10)13-19-12(14(21)22)11-3-1-2-8-20(11)13/h1-8H,(H,21,22)

Standard InChI Key:  CYOVWWMERMEXDJ-UHFFFAOYSA-N

Associated Targets(non-human)

DNA 1199 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 306.24Molecular Weight (Monoisotopic): 306.0616AlogP: 3.72#Rotatable Bonds: 2
Polar Surface Area: 54.60Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.00CX Basic pKa: 5.45CX LogP: 1.69CX LogD: 0.09
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.78Np Likeness Score: -1.43

References

1. Kamal A, Ramakrishna G, Ramaiah MJ, Viswanath A, Rao AVS, Bagul C, Mukhopadyay D, Pushpavalli SNCVL, Pal-Bhadra M.  (2013)  Design, synthesis and biological evaluation of imidazo[1,5-a]pyridinePBD conjugates as potential DNA-directed alkylating agents,  (4): [10.1039/C2MD20219K]

Source